Clinical Trial Update: A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cabiralzumab alone or with nivolumab in advanced malignancies; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancies

Drugs mentioned

• cabiralzumab (cabiralzumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2020-12-21